Calcium Carbonate-Core Liposome-Embedded Thermosensitive PLGA-PEG-PLGA Hydrogel Combined with Ultrasound for Eradication of Residual Hepatocellular Carcinoma After Radiofrequency Ablation
Pharmaceutics · 07.11.2026 · 18 (11) · 1446
DOI: 10.3390/pharmaceutics18111446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.11.2026. Verfasst von Yang He und 8 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liaoning Province science and technology joint plan, Natural Science Foundation Program of Liaoning Province project, Research Fund Project of Air Force Medical University.
Abstract (Originalsprache)
Background
Residual cancer cells stay on the ablation edge after radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). These leftover cells often bring local tumor recurrence. A pH and temperature dual-sensitive drug delivery system was built to handle this issue. Doxorubicin-filled calcium carbonate nanoparticles get wrapped by liposomes (DOX@CaCO3@Lip). These particles sit inside thermosensitive PLGA–PEG–PLGA hydrogel to form DCL-Gel. External ultrasound (US) pairs with this gel to wipe out the remaining HCC cells.
Methods
DOX@CaCO3@Lip nanoparticles were produced using gas diffusion. The particles spread evenly in 20 wt% PLGA–PEG–PLGA copolymer liquid. Researchers checked particle size, zeta potential, TEM shape, drug loading (DL%) and encapsulation efficiency (EE%). DCL-Gel was tested for liquid-gel shift, rheological behavior, stickiness, SEM appearance, stability and drug release triggered by pH or US. Heat-exposed HepG2 cells and an orthotopic HCC mouse model that mimics incomplete RFA were used to fully assess the combined treatment effects of DCL-Gel + US.
Results
PLGA–PEG–PLGA shifts from liquid to gel at 34–35 °C. DOX@CaCO3@Lip shows an average size of 148 nm and zeta potential of −8.65 mV. Its encapsulation efficiency hits 81.4% and drug loading reaches 11.5%. DCL-Gel can release doxorubicin slowly for as long as 14 days. Mild acidic surroundings (pH 6.2) and US both quicken drug release. The DCL-Gel + US group cuts HepG2 cell viability down to 18.6% and raises apoptosis rate to 71.3%. In animal tests, this group produces the best suppression of tumor growth. It lengthens median survival and lowers systemic drug toxicity.
Conclusions
The DCL-Gel + US setup relies on pH-sensitive calcium carbonate carriers, liposome fusion, thermosensitive hydrogel anchoring and US-aided drug penetration. It offers a safe and effective route to clear residual HCC after RFA. This strategy serves as a helpful auxiliary therapy to stop local relapse after thermal ablation.
Förderung
- Liaoning Province science and technology joint plan
- Natural Science Foundation Program of Liaoning Province project
- Research Fund Project of Air Force Medical University
- Special Program for Cultivation & Empowerment of Young Physicians, Xijing Hospital
Zitieren
APA
He, Y., Yu, J., Gu, D., Qin, H., Li, W., Lan, R., Wang, Y., Ye, W., & He, G. (2026). Calcium Carbonate-Core Liposome-Embedded Thermosensitive PLGA-PEG-PLGA Hydrogel Combined with Ultrasound for Eradication of Residual Hepatocellular Carcinoma After Radiofrequency Ablation. Pharmaceutics, 18(11), 1446. https://doi.org/10.3390/pharmaceutics18111446
Vancouver
He Y, Yu J, Gu D, Qin H, Li W, Lan R, et al. Calcium Carbonate-Core Liposome-Embedded Thermosensitive PLGA-PEG-PLGA Hydrogel Combined with Ultrasound for Eradication of Residual Hepatocellular Carcinoma After Radiofrequency Ablation. Pharmaceutics. 2026;18(11):1446. doi:10.3390/pharmaceutics18111446
BibTeX
@article{He2026,
author = {He, Yang and Yu, Jiping and Gu, Dongyue and Qin, Haiying and Li, Wantao and Lan, Rongjie and Wang, Yaqin and Ye, Weiliang and He, Guangbin},
title = {Calcium Carbonate-Core Liposome-Embedded Thermosensitive PLGA-PEG-PLGA Hydrogel Combined with Ultrasound for Eradication of Residual Hepatocellular Carcinoma After Radiofrequency Ablation},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {11},
pages = {1446},
doi = {10.3390/pharmaceutics18111446}
}
EUVIMED